ADVFN - Advanced Financial Network.
HOME» NYSE » J » JNJ Stock Price » JNJ Stock News

Johnson & Johnson Share News

 Johnson & Johnson Stock Price
JNJ Stock Price
 Johnson & Johnson Stock Chart
JNJ Stock Chart
 Johnson & Johnson Stock News
JNJ Stock News
 Johnson & Johnson Company Information
JNJ Company Information
 Johnson & Johnson Stock Trades
JNJ Stock Trades

Danaher, Blackstone Working on Bid for J&J's Ortho Unit

Danaher Corp. (DHR) and Blackstone Group LP (BX) are working on a joint bid for Johnson & Johnson's (JNJ) Ortho Clinical Diagnostics unit, Reuters reported Thursday, citing people familiar with the matter. Other bidders include Carlyle Group LP (CG), Bain Capital LLC, BC Partners and a joint approach from CVC Capital Partners and Leonard Green & Partners, Reuters reported. Ortho could be sold for more than $4 billion, the people told Reuters. Full story at Write to Subscribe to WSJ:

Stock News for Johnson & Johnson (JNJ)
10/20/201616:10:00Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter...
10/20/201606:32:00E.ON to Invest $500 Million in Illinois Wind Farm
10/19/201610:40:00Johnson & Johnson Opens New Global Services Center In Tampa...
10/19/201609:48:00Ortho Clinical Diagnostics to Present Data on Automation in Immunohematology...
10/19/201603:03:00J&J Brushes Off Pfizer's Challenge -- WSJ
10/18/201612:43:00J&J Brushes off Looming Biosimilar Competition -- 2nd Update
10/18/201609:15:00J&J Again Buoyed by Pharmaceuticals -- Update
10/18/201608:17:50Current Report Filing (8-k)
10/18/201608:10:00J&J Again Buoyed by Pharmaceuticals
10/18/201607:49:00Johnson & Johnson Again Buoyed by Pharmaceuticals
10/18/201606:40:00Johnson & Johnson Reports 2016 Third-Quarter Results:
10/17/201619:16:00Pfizer Plans to Launch Remicade Biosimilar in November -- Update
10/17/201618:40:00Depomed to Add Starboard Nominees
10/17/201618:40:00Pfizer Plans to Launch Remicade Biosimilar in November
10/17/201618:36:00JPMorgan Sees $1 Billion In Lost J&J Sales On Pfizer Biosimilar...
10/17/201618:06:00Pfizer Plans to Launch Remicade Biosimilar in November
10/07/201603:51:00Correction to AstraZeneca Story
10/07/201603:00:00AstraZeneca Signs $330 Million Deal with Johnson & Johnson Affiliate
10/04/201616:30:00J&J Warns Insulin Pump Vulnerable to Cyber Hacking
10/04/201616:26:00J&J Warns Insulin Pump Vulnerable to Cyber Hacking

Johnson & Johnson and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations